NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) Issues Quarterly Earnings Results

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) announced its earnings results on Tuesday. The company reported C($0.16) EPS for the quarter, FiscalAI reports. The firm had revenue of C$109.80 million during the quarter. NorthWest Health Prop Real Est Inv Trust had a negative return on equity of 14.67% and a negative net margin of 75.29%.

NorthWest Health Prop Real Est Inv Trust Stock Performance

Shares of NorthWest Health Prop Real Est Inv Trust stock traded down C$0.02 on Tuesday, reaching C$6.00. 714,321 shares of the stock were exchanged, compared to its average volume of 688,557. NorthWest Health Prop Real Est Inv Trust has a twelve month low of C$4.44 and a twelve month high of C$6.07. The business has a 50 day moving average price of C$5.53 and a two-hundred day moving average price of C$5.26. The company has a quick ratio of 0.06, a current ratio of 0.25 and a debt-to-equity ratio of 129.42. The firm has a market capitalization of C$1.49 billion, a price-to-earnings ratio of 29.68, a PEG ratio of 0.74 and a beta of 1.78.

Analyst Ratings Changes

NWH.UN has been the topic of several analyst reports. Royal Bank Of Canada set a C$5.50 price target on shares of NorthWest Health Prop Real Est Inv Trust and gave the stock a “sector perform” rating in a report on Monday, November 24th. Canadian Imperial Bank of Commerce raised their price objective on NorthWest Health Prop Real Est Inv Trust from C$5.50 to C$5.75 in a research report on Thursday, November 13th. Scotiabank boosted their target price on NorthWest Health Prop Real Est Inv Trust from C$6.50 to C$7.00 in a research note on Thursday, November 13th. Finally, BMO Capital Markets upped their target price on NorthWest Health Prop Real Est Inv Trust from C$5.00 to C$6.00 in a research report on Thursday, November 13th. One equities research analyst has rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of C$6.00.

NorthWest Health Prop Real Est Inv Trust Company Profile

Northwest Healthcare Properties Real Estate Investment Trust provides investors with access to a portfolio of high-quality healthcare real estate. The company provides investors exposure to a well-diversified portfolio of healthcare real estate located in the greater areas of cities such as Australasia, Brazil, Germany, and Canada of which Australasia derives a majority of revenue to the company.